Cover

Controversies in Acute Kidney Injury

Editor(s): Kellum J.A. (Pittsburgh, Pa.) 
Ronco C. (Vicenza) 
Vincent J.-L. (Brussels) 
Table of Contents
Vol. 174, 2011
Section title: Prevention/Treatment/Rehabilitation: What’s on the Horizon?
Kellum JA, Ronco C, Vincent J-L (eds): Controversies in Acute Kidney Injury. Contrib Nephrol. Basel, Karger, 2011, vol 174, pp 163–172
(DOI:10.1159/000329394)

Acute Kidney Injury in Children: Prevention, Treatment and Rehabilitation

Goldstein S.L.
University of Cincinnati College of Medicine, Director, Center for Acute Care Nephrology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Pediatric acute kidney injury (AKI) epidemiology has shifted from primary kidney disease to secondary to another organ system illness or its treatment with nephrotoxic medications. Similar to adult patients, critically ill children with AKI with multiorgan failure exhibit high mortality rates, yet conducting interventional trials to prevent, treat or mitigate the effects of AKI in children have been hampered by relatively low event rates and the reliance on serum creatinine as the biomarker of AKI. However, recent advancements in standardizing the AKI definition via the pediatric modified RIFLE criteria, multicenter collaboration via the Prospective Pediatric CRRT Registry Group and multiple validation studies of novel AKI biomarkers in children have provided the essential components to evaluate preventive and therapeutic strategies to attack pediatric AKI as a disease state. The scope of this article is to review the advancements in the study of pediatric AKI over the past decade and offer a compelling and bright view of what is on the horizon for the prevention, treatment and rehabilitation of AKI in kids.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Warady BA Bunchman T: Dialysis therapy for children with acute renal failure: survey results. Pediatr Nephrol 2000; 15: 11-13
  2. Vachvanichsanong P Dissaneewate P Lim A McNeil E: Childhood acute renal failure: 22-year experience in a university hospital in southern Thailand. Pediatrics 2006; 118: e786-e791
  3. Hui-Stickle S Brewer ED Goldstein SL: Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 2005; 45: 96-101
  4. Williams DM Sreedhar SS Mickell JJ Chan JC: Acute kidney failure: a pediatric experience over 20 years. Arch Pediatr Adolesc Med 2002; 156: 893-900
  5. Zappitelli M Moffett BS Hyder A Goldstein SL: Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study. Nephrol Dial Transplant 2011; 26: 144-150
  6. Moffett BS Goldstein SL: Pediatric acute kidney injury is associated with increasing nephrotoxic medication exposure. Clin J Am Soc Nephrol 2011; 6: 856-863
  7. Bailey D Phan V Litalien C, et al: Risk factors of acute renal failure in critically ill children: a prospective descriptive epidemiological study. Pediatr Crit Care Med 2007; 8: 29-35
  8. Mishra J Dent C Tarabishi R, et al: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231-1238
  9. Dent CL Ma Q Dastrala S, et al: Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007; 11: R127
  10. Bennett M Dent CL Ma Q, et al: Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008; 3: 665-673
  11. Price JF Mott AR Dickerson HA, et al: Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome?. Pediatr Crit Care Med 2008; 9: 279-284
  12. Akcan-Arikan A Zappitelli M Loftis LL Washburn KK Jefferson LS Goldstein SL: Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007; 71: 1028-1035
  13. Plotz FB Bouma AB van Wijk JA Kneyber MC Bokenkamp A: Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE criteria. Intensive Care Med 2008; 34: 1713-1717
  14. Palmieri T Lavrentieva A Greenhalgh D: An assessment of acute kidney injury with modified RIFLE criteria in pediatric patients with severe burns. Intensive Care Med 2009; 35: 2125-2129
  15. Zappitelli M Parikh CR Akcan-Arikan A Washburn KK Moffett BS Goldstein SL: Ascertainment and epidemiology of acute kidney injury varies with definition interpretation. Clin J Am Soc Nephrol 2008; 3: 948-954
  16. Schneider J Khemani R Grushkin C Bart R: Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit. Crit Care Med 2010; 38: 933-999
  17. Zappitelli M Bernier PL Saczkowski RS, et al: A small post-operative rise in serum creatinine predicts acute kidney injury in children undergoing cardiac surgery. Kidney Int 2009; 76: 885-892
  18. Blinder JJ Goldstein SL Lei VV, et al: Acute kidney injury occurs frequently in infants undergoing congenital heart surgery. J Thorac Cardiovasc Surg submitted
  19. Goldstein SL Chawla LS: Renal angina. Clin J Am Soc Nephrol 2010; 5: 943-949
  20. Murphy CV Schramm GE Doherty JA, et al: The importance of fluid management in acute lung injury secondary to septic shock. Chest 2009; 136: 102-109
  21. Foland JA Fortenberry JD Warshaw BL, et al: Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med 2004; 32: 1771-1776
  22. Gillespie RS Seidel K Symons JM: Effect of fluid overload and dose of replacement fluid on survival in hemofiltration. Pediatr Nephrol 2004; 19: 1394-1399
  23. Goldstein SL Currier H Graf C Cosio CC Brewer ED Sachdeva R: Outcome in children receiving continuous venovenous hemofiltration. Pediatrics 2001; 107: 1309-1312
  24. Goldstein SL Somers MJ Baum MA, et al: Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int 2005; 67: 653-658
  25. Hayes LW Oster RA Tofil NM Tolwani AJ: Outcomes of critically ill children requiring continuous renal replacement therapy. J Crit Care 2009; 24: 394-400
  26. Sutherland SM Zappitelli M Alexander SR, et al: Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 2010; 55: 316-325
  27. Zappitelli M Washburn KK Arikan AA, et al: Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care 2007; 11: R84
  28. Washburn KK Zappitelli M Arikan AA, et al: Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children. Nephrol Dial Transplant 2008; 23: 566-572
  29. Askenazi DJ Feig DI Graham NM Hui-Stickle S Goldstein SL: 3-5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int 2006; 69: 184-189
  30. Garg AX Suri RS Barrowman N, et al: Longterm renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 2003; 290: 1360-1370


Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00